KKR-backed Panasonic Healthcare agreed on Wednesday to buy Bayer Diabetes Care for €1 billion ($1.1 billion) in a rare example of a foreign private equity group and a Japanese company jointly making a large overseas acquisition.
¬ Haymarket Media Limited. All rights reserved.
